“Leptomeningeal metastases (LM) is significantly underdiagnosed because current tests such as MRI and cytology lack sensitivity,” said Priya U. Kumthekar, M.D., Associate Professor of Neurology (Neuro-oncology) and Medicine (Hematology and Oncology) at Northwestern University & The Feinberg School of Medicine.

“My colleagues and I are pleased to see that Plus has acquired the CNSide assay that we have found to be a highly sensitive diagnostic for LM and a game changer for the overall clinical management of LM.”

PR: https://bit.ly/4dB1tHg